News & Updates
Filter by Specialty:
Pandemic interventions help lessen invasive bacterial infections in children
The implementation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic has significantly reduced the incidences of S. pneumoniae and Salmonella spp. among nine major pathogens of invasive bacterial infection (IBI) in children, reports a study.
Pandemic interventions help lessen invasive bacterial infections in children
07 Feb 2022Patient ethnicity, HBV genotype predict functional cure after therapy withdrawal
The chances of hepatitis B surface antigen (HBsAg) loss after withdrawing nucleo(s)tide analogue (NUC) treatment depend on factors such as patient ethnicity, end-of-treatment antigen levels, and HBV genotype, a new study reports.
Patient ethnicity, HBV genotype predict functional cure after therapy withdrawal
06 Feb 2022Wearing of face masks does not make people complacent about social distancing
The use of face masks during the COVID-19 pandemic does not reduce compliance to social distancing or other public health control measures, a recent study has found.
Wearing of face masks does not make people complacent about social distancing
06 Feb 2022Systemic inflammation mediates obesity-related severe COVID-19
Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.
Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022Singapore’s home test catches smell, taste loss in COVID-19 patients
The Singapore Smell and Taste Test (SSTT), a personal testing kit for the daily home- and self-assessment of smelling and tasting functions, can objectively assess sensory losses in patients with the coronavirus disease 2019 (COVID-19) and align well with self-reported measures of sensory function, according to a recent study.
Singapore’s home test catches smell, taste loss in COVID-19 patients
04 Feb 2022Quercetin augments therapeutic benefit of antivirals for COVID-19
In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.